{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-016890","form_type":"8-K","ticker":"QUCY","cik":"0001874252","company_name":"Quantum Cyber N.V.","filed_at":"2026-02-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.642275+00:00","generated_at":"2026-05-16T02:32:43.434349+00:00","sec_items":["1.01","5.02","3.02","3.03","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Mainz Biomed secures $6M private placement, names David Lazar Chairman; pivots to pancreatic cancer","bullets":["First tranche of $3M closed Feb 13; second $3M expected after shareholder approval by April 15, 2026.","Preferred shares convertible into up to 95%+ of fully diluted shares; Lazar appointed Chairman and gets board nomination rights.","Company to focus on U.S. pancreatic cancer detection, evaluate sale of colorectal assets, wind down German sub.","Settlement agreements with officers/directors require ~$1.9M aggregate payments upon final closing."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-016890","json":"https://secwatch.observer/filing/0001213900-26-016890.json","markdown":"https://secwatch.observer/filing/0001213900-26-016890.md","text":"https://secwatch.observer/filing/0001213900-26-016890.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1874252/000121390026016890/0001213900-26-016890-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1874252/000121390026016890/ea0277246-8k_mainz.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T02:32:43.434349+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2f449e1424330d90f6d353cf913663cfa2d6c0ad","claim":"Quantum Cyber N.V. issued 1,000,000 of our series A preferred shares, with a nominal value of €0.01 per share of preferred stock to David E. Lazar for $1.00 per share for aggregate gross proceeds of $3 million.","evidence_excerpt":"the Series B Preferred Shares, the “First Closing Shares”), convertible, subject to shareholder approval, into an aggregate of up to 9 million Ordinary Shares in exchange for $3 million; and ● (a) 1,000,000 of our series D preferred shares, with a nominal value of €0.01 per share (the “Series D Preferred Shares”), convertible into an aggregate of up to 225","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1874252/000121390026016890/0001213900-26-016890-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"preferred stock"},{"label":"Shares","value":"1,000,000 of our series A preferred shares, with a nominal value of €0.01 per share"},{"label":"Purchaser","value":"David E. Lazar"},{"label":"Consideration","value":"$1.00 per share for aggregate gross proceeds of $3 million"}],"fact_type":"equity_issuance"},{"claim_id":"3285b4bde1a47341d45030d3480bb286385c4fa4","claim":"Quantum Cyber N.V. issued 1,000,000 of our series C preferred shares, with a nominal value of €0.01 per share of preferred stock to David E. Lazar for $1.00 per share for aggregate gross proceeds of $3 million.","evidence_excerpt":"the Series B Preferred Shares, the “First Closing Shares”), convertible, subject to shareholder approval, into an aggregate of up to 9 million Ordinary Shares in exchange for $3 million; and ● (a) 1,000,000 of our series D preferred shares, with a nominal value of €0.01 per share (the “Series D Preferred Shares”), convertible into an aggregate of up to 225","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1874252/000121390026016890/0001213900-26-016890-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"preferred stock"},{"label":"Shares","value":"1,000,000 of our series C preferred shares, with a nominal value of €0.01 per share"},{"label":"Purchaser","value":"David E. Lazar"},{"label":"Consideration","value":"$1.00 per share for aggregate gross proceeds of $3 million"}],"fact_type":"equity_issuance"},{"claim_id":"c1083e04ab545e51a0a7d7c52f38d6f2c9d46cc6","claim":"Quantum Cyber N.V. issued 1,000,000 of our series E preferred shares, with a nominal value of €0.01 per share of preferred stock to David E. Lazar for $1.50 per share for aggregate gross proceeds of $3 million.","evidence_excerpt":"The First Closing Shares are subject to certain conversion limitations as described below. Simultaneous to entering into the Purchase Agreement on February 13, 2026, Mr. Lazar purchased the First Closing Shares at a price of $1.00 per share for aggregate gross proceeds of $3 million (the “First Closing”). The Purchase Agreement also contemplates that Mr. Lazar will separately purchase and acquire the Second Closing Shares as soon as practicable after we receive the Conversion Approval (as defined below) at a price of $1.50 per share for aggregate gross proceeds of $3 million","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1874252/000121390026016890/0001213900-26-016890-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"preferred stock"},{"label":"Shares","value":"1,000,000 of our series E preferred shares, with a nominal value of €0.01 per share"},{"label":"Purchaser","value":"David E. Lazar"},{"label":"Consideration","value":"$1.50 per share for aggregate gross proceeds of $3 million"}],"fact_type":"equity_issuance"},{"claim_id":"c623c00082227f6760ca42c99d1ee0964b2a2047","claim":"Quantum Cyber N.V. issued 1,000,000 of our series D preferred shares, with a nominal value of €0.01 per share of preferred stock to David E. Lazar for $1.50 per share for aggregate gross proceeds of $3 million.","evidence_excerpt":"The First Closing Shares are subject to certain conversion limitations as described below. Simultaneous to entering into the Purchase Agreement on February 13, 2026, Mr. Lazar purchased the First Closing Shares at a price of $1.00 per share for aggregate gross proceeds of $3 million (the “First Closing”). The Purchase Agreement also contemplates that Mr. Lazar will separately purchase and acquire the Second Closing Shares as soon as practicable after we receive the Conversion Approval (as defined below) at a price of $1.50 per share for aggregate gross proceeds of $3 million","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1874252/000121390026016890/0001213900-26-016890-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"preferred stock"},{"label":"Shares","value":"1,000,000 of our series D preferred shares, with a nominal value of €0.01 per share"},{"label":"Purchaser","value":"David E. Lazar"},{"label":"Consideration","value":"$1.50 per share for aggregate gross proceeds of $3 million"}],"fact_type":"equity_issuance"},{"claim_id":"d71b394a8ed978167a4a99cd2952119294e3d630","claim":"Quantum Cyber N.V. issued 1,000,000 of our series B preferred shares, with a nominal value of €0.01 per share of preferred stock to David E. Lazar for $1.00 per share for aggregate gross proceeds of $3 million.","evidence_excerpt":"the Series B Preferred Shares, the “First Closing Shares”), convertible, subject to shareholder approval, into an aggregate of up to 9 million Ordinary Shares in exchange for $3 million; and ● (a) 1,000,000 of our series D preferred shares, with a nominal value of €0.01 per share (the “Series D Preferred Shares”), convertible into an aggregate of up to 225","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1874252/000121390026016890/0001213900-26-016890-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"preferred stock"},{"label":"Shares","value":"1,000,000 of our series B preferred shares, with a nominal value of €0.01 per share"},{"label":"Purchaser","value":"David E. Lazar"},{"label":"Consideration","value":"$1.00 per share for aggregate gross proceeds of $3 million"}],"fact_type":"equity_issuance"},{"claim_id":"eb6a708071f314b4551832b3ee1243fd1fd287f8","claim":"Quantum Cyber N.V. entered into Purchase Agreement with David E. Lazar valued at $3 million (effective 2026-02-13).","evidence_excerpt":"On February 13, 2026, we entered into a Securities Purchase Agreement (the “Purchase Agreement”) with David E. Lazar that provides for the sale in a private placement of:","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1874252/000121390026016890/0001213900-26-016890-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"David E. Lazar"},{"label":"Value","value":"$3 million"},{"label":"Effective","value":"2026-02-13"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}